A leading medical institution of Latvia – Rīga Stradiņš University has founded the Nuclear Medicine Clinic to improve cancer diagnostics by PET/CT technology – most innovative and precise diagnostic method for detection of oncological diseases. Nuclear Medicine Clinic is trustworthy because it has designated the area of expertise and meets all European standards, incorporating all aspects of oncological radioisotope imaging for a wide range of malignant disease, including one of the newest and most specific radiotracer for prostate cancer diagnostics Ga-PSMA.
Rīga Stradiņš University Radiology Scientific laboratory is involved in the research of newest radiotracers of PET/CT technology and provides scientific support for the Clinic. The Cyclotron Complex at the Nuclear Medicine Clinic is very important for the quality of PET/CT examination, because PET/CT scan is carried out by using self-made radiopharmaceuticals, eliminating the need to acquire the necessary preparations from other manufacturers, thereby additionally guaranteeing compliance of the preparation with patient-specific needs.
TIME of FLIGHT (ToF) technology, using very sensitive detectors that are not available on most other systems. This offers images of exceptional quality and shortest possible scan time.
64 SLICE CT provides the highest scan resolution and the best accuracy of the images.
OPENVIEW GANTRY enhances patient comfort providing easy patient access for clinicians, especially for pediatric and claustrophobic patients.
DOSE WISE and SMART BEAM MANAGEMENT encompasses a set of techniques, programs and practices that ensures optimal Image Quality while protecting people in the X-ray environments. The result is improved Image Quality at a significantly lower effective dose which contributes to the safety of patients and staff. This technology has been scientifically documented to reduce radiation dose.
INDIVIDUAL APPROACH to each patient, trying to find the most optimal solutions for medical consultation, examination and medical tourism offers. Friendly and reassuring environment for patients, offering an excellent service.
DOCTORS are highly skilled and experienced professionals with international educational and training background in the area of Nuclear Medicine, speaking English, Russian and Latvian.
PERSONALIZED MEDICINE is provided by having the ability to look at a patient on an individual basis. By molecular imaging diseases can be diagnosed at a much earlier stage and individualized therapies applied.
AFFORDABLE COST AND QUALITY of our PET/CT diagnostics can help to predict the right therapy with the fewest side effects for individual patients. It can improve the quality of care and decrease cost at the same time.
Diagnosed with cancer and are undergoing active treatment, assess treatment response efficiency and perform cancer monitoring with PET/CT Scan!
Facing a post treatment surveillance stage, undergo early diagnosis of possible cancer recurrence to ensure timely and maximally efficient repeated treatment, if necessary!
It is important to emphasize that PET/CT is a multimodality whole-body scan. Other conventional high-resolution modalities as CT alone and MR excel at providing structural details however they provide little insight into tumor physiology. PET is used to provide insight into a tumor's biologic functions and its surrounding microenvironment. Thus, PET may detect biochemical changes in an organ or tissue that can identify the onset of a disease process before anatomical changes related to the disease can be seen with other imaging processes, such as computed tomography (CT scan) or magnetic resonance imaging (MRI).
There are oncological diseases as e.g. ovarian cancer when we see an elevated CA-125 level in dynamic modelling at the stage where no changes are yet demonstrated by ultrasound and computer tomography (CT). It is one of clinical situations when PET/CT scan, due to its sensitivity and specificity, will disclose disease activity earlier. The imaging tool recognizes pathological formations from up to 1 cm in size and allows for identification of cancer-related formations.
According to literature – from up to 9 millimetres. But in practice we can see smaller ones. A lymph node of 4 millimetres in size, but it glows! We measure intensity of radiation accumulation, which is an objective parameter, and it shows that the node intensively consumes glucose. It is clear that the node is malignant.
Specifically, PET/CT studies evaluate the metabolism of a particular organ or tissue, so that information about the physiology (functionality) and anatomy (structure) of the organ or tissue is evaluated, as well as its biochemical properties. Integrating PET with a CT maximizes their separate strengths and provides anatomic localization of physiologic processes with detailed visualization of a tumor's structure. The availability of multi-modality (hybrid) imaging with PET/CT improves our ability to characterize lesions and to affect treatment decisions and patient management.
We are pleased to be the first medicine centre in Latvia providing a wide range of cancer diagnostics with high quality PET/CT technology and especially proud to be among the rare European PET/CT centres offering progressive prostate cancer diagnostics with innovative 68Ga-PSMA. We are also proud to be the only PET/CT facility in the Baltic countries having on-site cyclotron for production of positron emitters and supplying them straight to the examination site. Rīga Stradiņš university Nuclear Medicine Clinic has formed a stable team of highly qualified professionals with international educational and training background in the Nuclear Medicine. I am sure that besides the high-quality examination the patient will also be pleased due to the very competitive price, knowledge of our professional staff and welcoming attitude.